Cytotoxic lymphocyte heterogeneity in glioblastoma: insights from single-cell and spatial multiomics toward precision immunotherapeutic reprogramming - Summary - MDSpire

Cytotoxic lymphocyte heterogeneity in glioblastoma: insights from single-cell and spatial multiomics toward precision immunotherapeutic reprogramming

  • By

  • Wentao Dong

  • Yang Li

  • Zhuolin Wu

  • Quanlin Fu

  • Jinshuang Zhao

  • Bangyue Wang

  • Jia Yao

  • Chenglu Lu

  • Minfeng Tong

  • June 10, 2026

  • 0 min

Share

Objective:

Emphasize the significance of tailored immunotherapeutic approaches.

Approach:
    Key Findings:
    • Clarify implications for immunotherapy.
    Interpretation:

    Make more concise.

    Limitations:
    • Expand to include future research directions.
    Conclusion:

    Reiterate importance of addressing unique challenges posed by GBM.

Original Source(s)

Cytotoxic lymphocyte heterogeneity in glioblastoma: insights from single-cell and spatial multiomics toward precision immunotherapeutic reprogramming

  • by Wentao Dong, Yang Li, Zhuolin Wu, Quanlin Fu, Jinshuang Zhao, Bangyue Wang, Jia Yao, Chenglu Lu, Minfeng Tong

  • June 10, 2026

Related Content

Obesity-driven metabolic reprogramming and immune dysfunction in renal cancer

A multicenter clinical study on transanal endoscopic sphincter-preserving resection of low rectal tumors

Editorial: Challenges and strategies in the management of ER/PgR Low-expression breast cancer: exploring fundamentals, clinical insights, and treatment approaches